CONMED Corporation
CNMD
$34.42
-$0.35-1.01%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 317.05M | 373.20M | 337.93M | 342.35M | 321.26M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 317.05M | 373.20M | 337.93M | 342.35M | 321.26M |
| Cost of Revenue | 135.50M | 196.81M | 148.41M | 148.93M | 140.10M |
| Gross Profit | 181.55M | 176.39M | 189.52M | 193.42M | 181.15M |
| SG&A Expenses | 148.48M | 134.42M | 139.00M | 137.82M | 144.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 300.31M | 346.13M | 301.31M | 300.88M | 297.94M |
| Operating Income | 16.74M | 27.07M | 36.62M | 41.46M | 23.32M |
| Income Before Tax | 18.36M | 29.25M | 4.27M | 29.92M | 7.67M |
| Income Tax Expenses | 4.53M | 12.51M | 1.41M | 8.50M | 1.64M |
| Earnings from Continuing Operations | 13.83M | 16.74M | 2.86M | 21.42M | 6.04M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.83M | 16.74M | 2.86M | 21.42M | 6.04M |
| EBIT | 16.74M | 27.07M | 36.62M | 41.46M | 23.32M |
| EBITDA | 35.57M | 44.72M | 55.23M | 60.03M | 41.57M |
| EPS Basic | 0.45 | 0.54 | 0.09 | 0.69 | 0.19 |
| Normalized Basic EPS | 0.20 | 0.39 | 0.59 | 0.67 | 0.30 |
| EPS Diluted | 0.45 | 0.54 | 0.09 | 0.69 | 0.19 |
| Normalized Diluted EPS | 0.20 | 0.39 | 0.58 | 0.67 | 0.30 |
| Average Basic Shares Outstanding | 30.59M | 30.97M | 30.96M | 30.95M | 30.97M |
| Average Diluted Shares Outstanding | 30.62M | 31.03M | 31.05M | 31.05M | 31.15M |
| Dividend Per Share | -- | 0.00 | 0.20 | 0.20 | 0.20 |
| Payout Ratio | -- | 36.99% | 216.47% | 28.88% | 102.39% |